What’s Your Workout?
A Boxer’s Regimen to Stay Undefeated
Having put off a finance career for fighting, light heavyweight Mike Lee explains how he trains.
Health & Wellness
Merck KGaA Chief Executive Stefan Oschmann put the Germany company’s consumer-health unit on the block in a move that will focus its health-care activities on the riskier business of developing prescription medicines.
What’s Your Workout?
Forget the Gym—She’ll Stick With Field Hockey
After playing the sport in college and internationally, designer Nina Cheng finds the game she loves in the middle of New York City.
Health & Wellness
Bargaining With Cancer Patients About Treatment
Surgeons at Memorial Sloan Kettering Cancer Center borrowed negotiating techniques from Harvard Business School to help some prostate-cancer patients decide on treatment.
Pfizer is bringing back a cancer drug it pulled from the U.S. market over safety concerns in 2010--but the second iteration carries a higher cost, in the latest sign of the industry’s pricing power.
Trevor Fetter will step down from his roles as chief executive and director by March 2018, the for-profit hospital chain said, as the company deals with investor pushback over its corporate strategy and recent board defections.
Abbott Laboratories released new software updates designed to protect hundreds of thousands of implanted pacemakers from external hacking and to guard against dangerous battery depletions in a different cardiac device linked to two patient deaths.
Gilead Sciences’ planned acquisition of Kite Pharma underscores the promise of a new type of treatment, called CAR-T, that uses the body’s own immune system to attack cancer.
Your Health
How You Walk Could Flag Mental Decline
A new study measuring the gaits of elderly people could lead to important insights about dementia, Alzheimer’s and more.
What’s Your Workout?
Table Tennis for One, With Help From a Robot
A California winemaker calls ping pong central to his fitness routine for its help with agility and even core strength.
Your Health
A Striking Rise in Serious Allergy Cases
Insurance claims for dangerous reactions to foods like peanuts, eggs and dairy have increased by nearly five times over the past decade.
What’s Your Workout?
Headfirst Down the River in a Bellyak
A North Carolina white-water expert sings the praises of the mashup of kayaking and surfing.
Ending treatment earlier may help prevent dangerous antibiotic resistance, but it’s not the best course of action all the time.
What’s Your Workout?
He’s Hardcore Into Softball at 81
A Massachusetts retiree reveals how he stays fit for pitching both ends of a double-header.
Your barber may have nothing to do with it.
The high price of Gilead Sciences’ HIV drug Truvada has deterred many countries from providing the pill as a preventive treatment for people at high risk of contracting the AIDS-causing virus. By rolling out the preventive treatment as a clinical trial, the NHS can use the generic version of the drug without infringing patents.
More than seven months after the introduction of a generic version of the allergy drug, the more expensive brand-name EpiPen still accounts for more than a quarter of the market. One reason is that a middleman can profit from the sale of such pricier medicines.
Your Workout
A Google Executive Does Cartwheels
Kari Clark’s routine mixes CrossFit with gymnastics; How the 39-year-old got serious about working out.
U.S. generic-drug prices are falling at the fastest rate in years, eating into the profits of pharmaceutical wholesalers and manufacturers alike and erasing billions of dollars of their market value in recent days.
Exercise fans are spending more money at boutique studios for specialty classes and spending less at gas stations, according to a new study.
ADVERTISEMENT
ADVERTISEMENT